The effect of metformin on the hypothalamic-pituitary-thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism

Journal of Clinical Pharmacology

Volumn 55, Issue 1, 2015, Pages 45-49

  Krysiak, Robert ^a   Okopien, Bogusław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

hypothyroidism; metformin; polycystic ovary syndrome; prediabetes; thyroid hormones; thyrotropin

Indexed keywords

BROMOCRIPTINE; GLUCOSE; METFORMIN; PROLACTIN; THYROID HORMONE; THYROTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS THYROID SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; OVARY POLYCYSTIC DISEASE; PROLACTIN BLOOD LEVEL; SUBCLINICAL HYPOTHYROIDISM; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; BLOOD; CLINICAL TRIAL; HYPOTHYROIDISM; MIDDLE AGED; THYROID GLAND;

ADULT; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; HYPOTHYROIDISM; METFORMIN; MIDDLE AGED; POLYCYSTIC OVARY SYNDROME; THYROID GLAND; THYROTROPIN;

EID: 84919711581     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/jcph.373     Document Type: Article

References (20)

1. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 2013; 36 (Suppl. 1): S11-S66.
2. Genuth S,. The UKPDS and its global impact. Diabet Med. 2008; 25 (Suppl. 2): 57-62.
3. Mahmood K, Naeem M, Rahimnajjad NA,. The Metformin: The hidden chronicles of a magic drug. Eur J Int Med. 2013; 24: 20-26.
4. Scarpello JH, Howlett HC,. Metformin therapy and clinical uses. Diab Vasc Dis Res. 2008; 5: 157-167.
5. Vigersky RA, Filmore-Nassar A, Glass AR,. Thyrotropin suppression by metformin. J Clin Endocrinol Metab. 2006; 91: 225-227.
6. Cappelli C, Rotondi M, Pirola I, et al. TSH-lowering effect of metformin in type 2 diabetic patients: Differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care. 2009; 32: 1589-1590.
7. Isidro ML, Penín MA, Nemiña R, Cordido F,. Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocrine. 2007; 32: 79-82.
8. Morteza Taghavi, Rokni S, Fatemi H,. Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. Diab Vasc Dis Res. 2011; 8: 47-48.
9. Oleandri SE, Maccario M, Rossetto R, et al. Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesity. J Endocrinol Invest. 1999; 22: 134-140.
10. Krysiak R, Okopien B,. Thyrotropin-lowering effect of metformin in a patient with resistance to thyroid hormone. Clin Endocrinol. 2011; 75: 404-406.
11. Brabant G, Ocran K, Ranft U, von zur Mühlen, Hesch RD,. Physiological regulation of thyrotropin. Biochimie. 1989; 71: 293-301.
12. Haugen BR,. Drugs that suppress TSH or cause central hypothyroidism. Best Pract Res Clinl Endocrinol Metab. 2009; 23: 793-800.
13. Labuzek K, Suchy D, Gabryel B, Bielecka A, Liber S, Okopien B,. Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide. Pharmacol Rep. 2010; 62: 956-965.
14. Pappa T, Alevizaki M,. Metformin and thyroid: An update. Eur Thyroid J. 2013; 2: 22-28.
15. Ortega-González C, Cardoza L, Coutiño B, Hidalgo R, Arteaga-Troncoso G, Parra A,. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome. J Endocrinol. 2005; 184: 233-239.
16. Iván G, Szigeti-Csúcs N, Oláh M, Nagy GM, Gõth MI,. Treatment of pituitary tumors: Dopamine agonists. Endocrine. 2005; 28: 101-110.
17. Chau-Van C, Gamba M, Salvi R, Gaillard RC, Pralong FP,. Metformin inhibits adenosine 5′-monophosphate-activated kinase activation and prevents increases in neuropeptide Y expression in cultured hypothalamic neurons. Endocrinology. 2007; 148: 507-511.
18. Duntas LH, Orgiazzi J, Brabant G,. The interface between thyroid and diabetes mellitus. Clin Endocrinol. 2011: 1-9.
19. Lõpez M, Varela L, Vázquez MJ, et al. Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med. 2010; 16: 1001-1008.
20. Rezzõnico J, Rezzõnico M, Pusiol E, Pitoia F, Niepomniszcze H,. Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord. 2011; 9: 69-75.